Compounds > 2,3,4,5-tetrahydroxypentanal
Page last updated: 2024-10-19

2,3,4,5-tetrahydroxypentanal and Ovarian Neoplasms

2,3,4,5-tetrahydroxypentanal has been researched along with Ovarian Neoplasms in 1 studies

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hossein, G1
Halvaei, S1
Heidarian, Y1
Dehghani-Ghobadi, Z1
Hassani, M1
Hosseini, H1
Naderi, N1
Sheikh Hassani, S1

Other Studies

1 other study available for 2,3,4,5-tetrahydroxypentanal and Ovarian Neoplasms

ArticleYear
Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
    Cancer medicine, 2019, Volume: 8, Issue:9

    Topics: Blood Proteins; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cystad

2019